MDNA Life Sciences Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MDNA Life Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014153
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and other cancers. It offers skin physical and skin care mitomic tests by using mtDNA-based biomarkers, to the skin care field. MDNA’s target therapy areas include prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, and endometriosis. The company’s tests are used for biomarker discovery, early disease detection, monitoring, risk assessment and therapeutic targeting. It caters to patients, medical providers and manufacturers of skin and sun care products. MDNA is headquartered in West Palm Beach, Florida, the US.

MDNA Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MDNA Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
MDNA Life Sciences Raises USD0.4 Million in Venture Financing 11
Partnerships 12
MDNA Life Sciences Enters into Agreement with University of Oxford 12
Licensing Agreements 13
BL&H Enter into Licensing Agreement with MDNA Life Sciences 13
MDNA Life Sciences Inc – Key Competitors 14
MDNA Life Sciences Inc – Key Employees 15
MDNA Life Sciences Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jan 08, 2016: MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MDNA Life Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
MDNA Life Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9
MDNA Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MDNA Life Sciences Raises USD0.4 Million in Venture Financing 11
MDNA Life Sciences Enters into Agreement with University of Oxford 12
BL&H Enter into Licensing Agreement with MDNA Life Sciences 13
MDNA Life Sciences Inc, Key Competitors 14
MDNA Life Sciences Inc, Key Employees 15

★海外企業調査レポート[MDNA Life Sciences Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • StemCells, Inc.:企業のM&A・事業提携・投資動向
    StemCells, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's StemCells, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D …
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • Bechtel Power Corp:企業の戦略的SWOT分析
    Bechtel Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Otonomy Inc (OTIC):企業の財務・戦略的SWOT分析
    Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Thales SA:企業の戦略・SWOT・財務情報
    Thales SA - Strategy, SWOT and Corporate Finance Report Summary Thales SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • BEENOS Inc.:企業のM&A・事業提携・投資動向
    BEENOS Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BEENOS Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • NaturalNano Inc (NNAN):企業の財務・戦略的SWOT分析
    Summary NaturalNano Inc (NaturalNano) is a nanomaterial company that develops and offers proprietary technologies and processes to provide nanotubes. The company’s products include PleximerTM, a turnkey HNT polymer concentrate available in pellet form that can be added directly into a polymer extrud …
  • General Electric Co (GE):石油・ガス:M&Aディール及び事業提携情報
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services ranging from aircraft engines, power generation and oil and gas production equipment to medical …
  • Victory Resources Corporation:企業の戦略・SWOT・財務情報
    Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Brazos Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Brazos Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Malayan Flour Mills Berhad:戦略・SWOT・企業財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Massachusetts Mutual Life Insurance Company:企業のM&A・事業提携・投資動向
    Massachusetts Mutual Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Massachusetts Mutual Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Ineos Group AG:企業の戦略的SWOT分析
    Ineos Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Century Aluminum Co:企業の戦略・SWOT・財務情報
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Omniox Inc-製薬・医療分野:企業M&A・提携分析
    Summary Omniox Inc (Omniox) is a biotechnology company that develops new medicines for hypoxic diseases. The company's H-NOX products are tailored for the treatment of hypoxic cancers, which include giloblastoma, metastatic brain cancer, head-and-neck cancer, pancreatic cancer, lung cancer, and pros …
  • Subaru Corporation (7270):企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆